Trade Summary

1 week ago, Ahmed Nadim, serving as Pres, CEO at Cullinan Therapeutics, Inc. (CGEM), sold 9,922 shares at $10.01 per share, for a total transaction value of $99,319.00. Following this transaction, Ahmed Nadim now holds 420,699 shares of CGEM.

This sale represents a 2.00% decrease in Ahmed Nadim's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, December 23, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 6 days after the trade was made.

Cullinan Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.